UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043952
Receipt number R000050045
Scientific Title Chronic effects of green propolis ingestion on energy expenditure by brown adipose tissue in humans
Date of disclosure of the study information 2022/03/31
Last modified on 2024/11/13 09:04:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Chronic effects of green propolis ingestion on energy expenditure by brown adipose tissue in humans

Acronym

Brown adipose tissue and green propolis

Scientific Title

Chronic effects of green propolis ingestion on energy expenditure by brown adipose tissue in humans

Scientific Title:Acronym

Brown adipose tissue and green propolis

Region

Japan


Condition

Condition

Healthy male volunteers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the chronic effects of green propolis containing artepirin C as main component on energy expenditure and to analyze its relation to brown adipose tissue activity and adiposity in humans.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Whole body energy expenditure assessed from respiratory gas analysis

Key secondary outcomes

respiratory quotient, adiposity


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Capsules containing 543 mg propolis were given daily for 4-5 weeks, and whole-body energy expenditure, respiratory quotient and adiposity were measured by indirect calorimetry at a resting state and after 2-hr cold exposure.

Interventions/Control_2

Placebo capsules were given daily for 4-6 weeks, and whole-body energy expenditure, respiratory quotient and adiposity were measured by indirect calorimetry at a resting state and after 2-hr cold exposure.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

35 years-old >

Gender

Male

Key inclusion criteria

1.Healthy male volunteers
2. Aged 20-35 years
3. Those who is not receiving medical treatment with drugs, therapies, or operations for seasonal, chronic, or idiopathic disorders.
4. Those with body mass index from18.5 to 30.0
5. Those who provided informed consent for participation

Key exclusion criteria

Body mass index >=30

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Yuko
Middle name
Last name Okamatsu

Organization

Hokkaido University

Division name

Faculty of Veterinary Medicine

Zip code

060-0818

Address

Kita18 Nishi9, Kita-ku, Sapporo

TEL

0117065205

Email

y-okamatsu@vetmed.hokudai.ac.jp


Public contact

Name of contact person

1st name Yuko
Middle name
Last name Okamatsu

Organization

Hokkaido University

Division name

Faculty of Veterinary Medicine

Zip code

060-0818

Address

Kita18 Nishi9, Kita-ku, Sapporo

TEL

0117065205

Homepage URL


Email

y-okamatsu@vetmed.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

Yamada Bee Company, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Tenshi College

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University

Address

Kita18 Nishi9, Kita-ku, Sapporo

Tel

011-706-5173

Email

syomu@vetmed.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

15

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 12 Month 10 Day

Date of IRB

2020 Year 12 Month 10 Day

Anticipated trial start date

2021 Year 01 Month 09 Day

Last follow-up date

2021 Year 05 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 04 Month 16 Day

Last modified on

2024 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050045